Paul Ko Ferrigno

Founder and CEO @Éclateral

Bristol, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2021 — Present

Founder and CEO @Éclateral

View department →

Bristol, GB

We’ve taken lateral flow tests and made the result invisible to the user, replacing the subjective visible line with an objective electrical measurement of the test and control lines. This means that any LFT or dipstick test can now be taken by patients at home with their clinicians still in control of the outcome- all while keeping the low cost/rapid readout of traditional LFTs.

EDUCATION

1987 — 1991

University of York

BSc, Cell Biology and Biochemistry

1996 — 2001

Dana-Farber Cancer Institute

Postdoctoral Fellow

1991 — 1996

University of Dundee

PhD, Biochemistry

SKILLS

Drug DiscoveryLifesciencesProtein ExpressionCell CultureTechnology TransferR&DGeneticsProteomicsLife SciencesCell BiologyBiotechnologyProtein PurificationResearch and Development (R&D)GenomicsSignal TransductionLaboratoryMolecular BiologyCancerAntibodiesTranslational ResearchPcrDnaWestern BlottingScienceBiochemistryCellProtein Chemistry

ABOUT PAUL KO FERRIGNO

Leading éclateral since co-founding it in 2020, raising over £3M to date to deliver home…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.